Clinical trial Recruiting at 1 site Observational Ages 18 and up

Collecting bio-specimens from high-risk patients for pancreatic cancer detection

Official title: Bio-Repository of High Risk Cohorts for the Early Detection of Pancreas Cancer

Run by Stanford University · NCT03260842 · Data updated 2026-11-12

This study is trying to collect samples from people with pancreatic cysts and those at high risk for pancreatic cancer to see if they can find early signs of the disease.

More Pancreatic Cyst trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment500 (estimated)
SponsorStanford University
Academic / other
Locations1 site (Stanford, California)
StatusRecruiting
StartedSeptember 1, 2017
Main results expectedApril 30, 2028
Study endsApril 30, 2030
Registry record updatedApril 1, 2025
Trial IDNCT03260842 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include individuals over 18 years old with pancreatic cysts or those at high risk for pancreatic cancer due to genetic factors or family history.

Probably not a fit

Patients who are unable to provide consent or unwilling to donate bio-specimens will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to create a bio-repository by collecting bio-specimens from two groups of patients: those diagnosed with pancreatic cysts and individuals identified as high risk for pancreatic cancer due to family history or genetic mutations. The study will gather pancreatic cyst fluid and blood samples using standardized protocols to facilitate early detection of pancreatic cancer. By analyzing these specimens, researchers hope to identify potential biomarkers that could lead to improved screening and diagnosis of this aggressive disease.

Why it matters

Potential benefit: If successful, this study could enhance early detection methods for pancreatic cancer, potentially leading to better patient outcomes.

How similar studies have gone: Other studies focusing on early detection and biomarker identification for pancreatic cancer have shown promise, indicating that this approach is both relevant and potentially impactful.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Older than 18 with pancreas cyst
* Older than 18 at high risk for Pancreas cancer

Exclusion Criteria:

* Unable to provide consent
* Not willing to provide bio-specimens

Where it's running

  • Stanford University
    Stanford, California, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.